Phreesia, Inc. PHR
Business Services · IPO 2019 · data as of November 13, 2026
Phreesia, Inc. (PHR) is a consumer discretionary company listed in the US with a market value of about $788M. In the twelve months to July 31, 2026 it had revenue of $508M and net income of $10M, a net margin of 2.1%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is shareholder returns (0/5).
Key numbers: a P/E of 74.6, a price to free cash flow of 9.8, 5-year revenue growth of 26% a year, a 5-year average ROIC of -25%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 55% below the current price.
About Phreesia
Phreesia is listed in the US and classified in business services, IPO year 2019. Revenue went from $80M in 2018 to $481M in 2026, growth of about 25.2% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 17% over three years (dilution for shareholders). It spends 25% of revenue on research and development.
Score: 2.0 / 5
Checks passed
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $508M | $481M | $420M | $356M | $281M | $213M | $149M | $125M | $100M | $80M |
| Net income | $10M | $2M | -$59M | -$137M | -$176M | -$118M | -$27M | -$20M | -$15M | -$18M |
| Free cash flow | $81M | $68M | $24M | -$38M | -$95M | -$93M | -$8M | -$6M | -$7M | -$18M |
| EPS (diluted) | $0.17 | $0.04 | $-1.02 | $-2.51 | $-3.36 | $-2.37 | $-0.69 | $-4.50 | $-24.53 | $-24.81 |
| Net margin | 2.1% | 0.5% | -13.9% | -38.4% | -62.7% | -55.4% | -18.4% | -16.3% | -15.1% | -22.8% |
| ROIC | — | -1.2% | -16.2% | -40.9% | -47.0% | -21.3% | -7.3% | -11.2% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 15 analysts is $13.87, 9% above the current price; targets range from $10.00 to $19.00; the consensus rating is “Buy”; expected EPS is $1.26 for the fiscal year ending January 31, 2027.
Frequently asked questions
What is Phreesia’s P/E ratio?
About 74.6, based on the last twelve months of diluted earnings per share (forward P/E about 8.5).
Is Phreesia stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 55% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Phreesia pay a dividend?
Not currently.
Is Phreesia a good stock to buy?
We do not give buy or sell advice. Phreesia scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.